1. Home
  2. SQNS vs XLO Comparison

SQNS vs XLO Comparison

Compare SQNS & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$3.06

Market Cap

48.0M

Sector

Technology

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.31

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
XLO
Founded
2003
2016
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.0M
49.8M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
SQNS
XLO
Price
$3.06
$8.31
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$20.33
$28.00
AVG Volume (30 Days)
273.3K
28.5K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$49.79
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$0.73
$0.46
52 Week High
$10.93
$9.25

Technical Indicators

Market Signals
Indicator
SQNS
XLO
Relative Strength Index (RSI) 38.68 52.36
Support Level $2.98 $7.47
Resistance Level $3.27 $8.80
Average True Range (ATR) 0.34 0.37
MACD -0.15 -0.05
Stochastic Oscillator 2.05 51.64

Price Performance

Historical Comparison
SQNS
XLO

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: